Loading …

Dendrogenix is a biopharmaceutical company based in Liège (Belgium) dedicated to developing first in class molecules named "Dendrogenins" addressing important medical needs in the field of neurodegenerative diseases, in particular in Hearing Loss indication, and in the field of Oncology.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.